{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:25:14Z","timestamp":1790727914836,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.revmed.2019.10.338","type":"journal-article","created":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T07:49:36Z","timestamp":1574581776000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mise au point sur la maladie des anticorps anti-membrane basale glom\u00e9rulaire ou syndrome de Goodpasture"],"prefix":"10.1016","volume":"41","author":[{"given":"C.","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Plaisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0300","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MAJ.0b013e31818fff94","article-title":"Landmark publication from The American Journal of the Medical Sciences: The significance of certain pulmonary lesions in relation to the etiology of influenza","volume":"338","author":"Goodpasture","year":"2009","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0305","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imj.1958.7.2.132","article-title":"Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis)","volume":"7","author":"Stanton","year":"1958","journal-title":"Australas Ann Med"},{"issue":"6","key":"10.1016\/j.revmed.2019.10.338_bib0310","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.7326\/0003-4819-60-6-1009","article-title":"Immune Aspects of the Glomerulonephritis Associated with Pulmonary Hemmorhage","volume":"60","author":"Scheer","year":"1964","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1016\/j.revmed.2019.10.338_bib0315","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.126.6.989","article-title":"The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis","volume":"126","author":"Lerner","year":"1967","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.revmed.2019.10.338_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012\u00a0revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"26","key":"10.1016\/j.revmed.2019.10.338_bib0325","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1016\/S0021-9258(18)37714-7","article-title":"Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV","volume":"263","author":"Saus","year":"1988","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.revmed.2019.10.338_bib0330","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.01380217","article-title":"Anti-Glomerular Basement Membrane Disease","volume":"12","author":"McAdoo","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0335","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ki.1973.14","article-title":"Anti-glomerular basement membrane antibody-induced glomerulonephritis","volume":"3","author":"Wilson","year":"1973","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.revmed.2019.10.338_bib0340","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0272-6386(96)90169-9","article-title":"Recurrent Goodpasture's disease","volume":"27","author":"Levy","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.revmed.2019.10.338_bib0345","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/j.1600-6143.2006.01502.x","article-title":"Recurrent glomerulonephritis after kidney transplantation","volume":"6","author":"Choy","year":"2006","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0350","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1523-1755.2005.67113.x","article-title":"Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury","volume":"67","author":"Dean","year":"2005","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.revmed.2019.10.338_bib0355","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1172\/JCI13876","article-title":"CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis","volume":"109","author":"Wu","year":"2002","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0360","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1681\/ASN.2007050546","article-title":"Healthy individuals have Goodpasture autoantigen-reactive T cells","volume":"19","author":"Zou","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.revmed.2019.10.338_bib0365","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa0910500","article-title":"Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis","volume":"363","author":"Pedchenko","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.revmed.2019.10.338_bib0370","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1046\/j.1523-1755.2003.00259.x","article-title":"Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease","volume":"64","author":"Salama","year":"2003","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.revmed.2019.10.338_bib0375","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1681\/ASN.V1291908","article-title":"In Goodpasture's disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1","volume":"12","author":"Salama","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.revmed.2019.10.338_bib0380","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2215\/CJN.13591215","article-title":"Spatial and Temporal Clustering of Anti-Glomerular Basement Membrane Disease","volume":"11","author":"Canney","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0385","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI108286","article-title":"Glomerulonephritis mediated by antibody to glomerular basement membrane. Immunological, clinical, and histopathological characteristics","volume":"57","author":"McPhaul","year":"1976","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.revmed.2019.10.338_bib0390","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00467-010-1663-2","article-title":"A 25-year experience with pediatric anti-glomerular basement membrane disease","volume":"26","author":"Williamson","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.revmed.2019.10.338_bib0395","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/j.ajkd.2010.09.022","article-title":"Clinical features and outcomes of anti-glomerular basement membrane disease in older patients","volume":"57","author":"Cui","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0400","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1309\/NPTP4UKV7JU3ELMQ","article-title":"Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80\u00a0cases","volume":"125","author":"Fischer","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.revmed.2019.10.338_bib0405","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMc0800484","article-title":"Anti-glomerular basement membrane disease after alemtuzumab","volume":"359","author":"Clatworthy","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.revmed.2019.10.338_bib0410","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ki.1997.27","article-title":"Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1\u00a0genes","volume":"51","author":"Fisher","year":"1997","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0415","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clim.2009.07.005","article-title":"The role of HLA-DRB1\u00a0alleles on susceptibility of Chinese patients with anti-GBM disease","volume":"133","author":"Yang","year":"2009","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.revmed.2019.10.338_bib0420","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/intimm\/dxp113","article-title":"Copy number variation of FCGR3A rather than FCGR3B and FCGR2B is associated with susceptibility to anti-GBM disease","volume":"22","author":"Zhou","year":"2010","journal-title":"Int Immunol"},{"issue":"8","key":"10.1016\/j.revmed.2019.10.338_bib0425","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/ndt\/gfh355","article-title":"Patients with Goodpasture's disease have two normal COL4A3\u00a0alleles encoding the NC1\u00a0domain of the type IV collagen alpha 3\u00a0chain","volume":"19","author":"Persson","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0430","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.autrev.2014.11.006","article-title":"Goodpasture's syndrome: a clinical update","volume":"14","author":"Greco","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.revmed.2019.10.338_bib0435","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1183\/09031936.93.05070804","article-title":"Iron content in human alveolar macrophages","volume":"5","author":"Corhay","year":"1992","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0440","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","article-title":"Rapidly progressive crescentic glomerulonephritis","volume":"63","author":"Jennette","year":"2003","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.revmed.2019.10.338_bib0445","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.autrev.2013.06.014","article-title":"Goodpasture's disease: a report of ten cases and a review of the literature","volume":"12","author":"Dammacco","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.revmed.2019.10.338_bib0450","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1681\/ASN.V10112446","article-title":"Anti-glomerular basement membrane disease","volume":"10","author":"Kluth","year":"1999","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0455","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000186552","article-title":"Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course","volume":"59","author":"Andrassy","year":"1991","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0460","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2012.375","article-title":"Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease","volume":"83","author":"Tang","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.revmed.2019.10.338_bib0465","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","article-title":"Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression","volume":"134","author":"Levy","year":"2001","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0470","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/md.0b013e318067da56","article-title":"Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28\u00a0cases","volume":"86","author":"Lazor","year":"2007","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.revmed.2019.10.338_bib0475","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/bmme.1996.0064","article-title":"Anti-glomerular basement membrane disease: role of enzyme-linked immunosorbent assays in diagnosis","volume":"59","author":"Litwin","year":"1996","journal-title":"Biochem Mol Med"},{"issue":"8","key":"10.1016\/j.revmed.2019.10.338_bib0480","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1440-1797.2011.01484.x","article-title":"Incidence and features of dual anti-GBM-positive and ANCA-positive patients","volume":"16","author":"De Zoysa","year":"2011","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.revmed.2019.10.338_bib0485","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2215\/CJN.05270515","article-title":"Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease","volume":"11","author":"Li","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.revmed.2019.10.338_bib0490","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","article-title":"Clinical features and outcome of patients with both ANCA and anti-GBM antibodies","volume":"66","author":"Levy","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0495","first-page":"107","article-title":"Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease","volume":"36","author":"Bosch","year":"1991","journal-title":"Clin Nephrol"},{"issue":"10","key":"10.1016\/j.revmed.2019.10.338_bib0500","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1681\/ASN.2010090928","article-title":"Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease","volume":"22","author":"Olson","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.revmed.2019.10.338_bib0505","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ndt\/gfu399","article-title":"Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort","volume":"30","author":"Alchi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2019.10.338_bib0510","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3389\/fimmu.2019.01665","article-title":"Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients","volume":"10","author":"Marques","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0515","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1681\/ASN.V83376","article-title":"Comparison of anti-GBM antibodies in sera with or without ANCA","volume":"8","author":"Hellmark","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0520","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo","year":"2017","journal-title":"Kidney Int"},{"issue":"7962","key":"10.1016\/j.revmed.2019.10.338_bib0525","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(76)93089-0","article-title":"Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome","volume":"1","author":"Lockwood","year":"1976","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.revmed.2019.10.338_bib0530","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","article-title":"Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study","volume":"90","author":"Cui","year":"2011","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.revmed.2019.10.338_bib0535","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000166666","article-title":"Plasma exchange in Goodpasture's syndrome","volume":"2","author":"Simpson","year":"1982","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.revmed.2019.10.338_bib0540","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2016.05.015","article-title":"Outcomes of patients with Goodpasture syndrome: A nationwide cohort-based study from the French Society of Hemapheresis","volume":"73","author":"Huart","year":"2016","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.revmed.2019.10.338_bib0545","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2019.10.338_bib0550","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2015.04.003","article-title":"Rituximab in anti-GBM disease: A retrospective study of 8\u00a0patients","volume":"60","author":"Touzot","year":"2015","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0555","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ki.1990.72","article-title":"Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis","volume":"37","author":"Jayne","year":"1990","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0560","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.ajkd.2004.09.029","article-title":"Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1\/alpha2\u00a0chains of type IV collagen","volume":"45","author":"Borza","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0565","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0272-6386(99)70084-3","article-title":"Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody","volume":"34","author":"Fervenza","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.revmed.2019.10.338_bib0570","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.V8111795","article-title":"Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease","volume":"8","author":"Kalluri","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.revmed.2019.10.338_bib0575","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0002-9343(88)90114-3","article-title":"Goodpasture's syndrome: recurrence after a five-year remission. Case report and review of the literature","volume":"84","author":"Klasa","year":"1988","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.revmed.2019.10.338_bib0580","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9343(87)90024-6","article-title":"Chronic recurrent Goodpasture's syndrome","volume":"82","author":"Mehler","year":"1987","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.revmed.2019.10.338_bib0585","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/ajkd.2000.8993","article-title":"Immunoadsorption in Goodpasture's syndrome","volume":"36","author":"Laczika","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.revmed.2019.10.338_bib0295","first-page":"570","article-title":"Renal transplantation for uncommon diseases. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association","volume":"14","author":"Briggs","year":"1999","journal-title":"Nephrol Dial Transplant"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631931118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886631931118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:41:48Z","timestamp":1759336908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024886631931118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S024886631931118X"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2019.10.338","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mise au point sur la maladie des anticorps anti-membrane basale glom\u00e9rulaire ou syndrome de Goodpasture","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2019.10.338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}